Only a few hundred out of the thousands of health claim applications submitted under the EU Nutrition and Health Claims Regulation are likely to gain approval, regulatory experts have predicted.
The biggest area of concern is botanicals, many of which will not make the grade if EFSA looks to human intervention studies as the primary source of evidence to support a claim, said Jean Savigny, senior partner at the Brussels office of legal firm Keller & Heckman.
Companies worried applications might be rejected should consider withdrawing them, he said. "You need to consider the economic damage of a rejection. If there is a real risk your application will be rejected, you should consider withdrawing it rather than being up there in a public list of ingredients that have been rejected."